⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17115852 | 0.91 | — | — | |
| SCHEMBL1975980 | 0.81 | — | — | |
| SCHEMBL1975532 | 0.78 | — | — | |
| SCHEMBL1973102 | 0.75 | — | — | |
| SCHEMBL1975271 | 0.75 | — | — | |
| SCHEMBL10972799 | 0.75 | — | — | |
| SCHEMBL10256 | 0.75 | — | — | |
| SCHEMBL31085539 | 0.73 | — | — | |
| SCHEMBL1976197 | 0.73 | — | — | |
| SCHEMBL38654528 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015039-B1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2008-08-27 | — | — | EP | claimed |
| EP-0935415-B1 | IN VITRO METHODS FOR DELIVERING NUCLEIC ACIDS INTO A CELL | IMARX PHARMACEUTICAL CORP (US) | 2006-11-22 | — | — | EP | claimed |